| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8537756 | Pulmonary Pharmacology & Therapeutics | 2018 | 7 Pages |
Abstract
In this brief communication, it was described the overreliance link generated between a young asthmatic subject and Short Acting Beta agonist (SABA) bronchodilator. It was an attempt to delineate the stages of this conflicting link where predominated the overreliance on SABA that might be one of the main circumstances surrounding near fatal asthma attack. New approach is needed from international guidelines to avoid development of such a problematic link between asthmatic subjects and SABA.
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
Luis J. Nannini,